baber/WOPTO huggingface dataset:
Patent AT-E316970-T1 (AT)
Inventor: OHUCHI YUTAKA
IPC: C07D215/54
Filed: 1995-05-18
Granted: 2006-02-15
Abstract: An 8-azabicycloÄ3.2.1Üoctan-3-one derivative of formula (30): <CHEM> wherein R is (CH2)qD or CH2CF3; q is an integer of 2 to 6; and D is a hydroxymethyl group, an alkoxy group having 2 to 6 carbon atoms or a morpholinyl group. These compounds are useful as intermediates for pharmaceuticals and agrochemicals.
Patent AT-E222208-T1 (AT)
Inventor: RAMBOZ MAURICE
IPC: B65G65/46
Filed: 1999-05-05
Granted: 2002-08-15
Abstract: The assembly consists of a pair of augers to discharge the material through a central outlet hopper (14), with drives situated between the horizontal branches (15,16) of a sideways U-shaped frame (4). The frame is hollow and has an access port (29) for maintenance via a chamber (B) beneath the assembly which is reached from outside the silo. The frame contains systems for handling and maneuvering the drives.
Patent AT-E252648-T1 (AT)
Inventor: TANIKAWA KOUJI
IPC: B01D15/18
Filed: 1999-02-05
Granted: 2003-11-15
Abstract: In demineralization of a beet sugar solution before boiling as the starting solution with a simulated moving bed chromatographic separator comprising a plurality of packed column units packed with a strongly acidic cation exchange resin in a salt form having an average grain size of 300 to 500 mum and a uniformity coefficient of at most 1.2 as chromatographic packing (separating packing), and each provided with a starting solution feed inlet, an eluent water feed inlet, a withdrawal outlet for a fraction of a component having a strong affinity for chromatographic packing ("strong-affinity component"), and a withdrawal outlet for a fraction of a component having a weak affinity for chromatographic packing ("weak-affinity component"); use is made of circulating pumps, the number of which is at least half of the number of the packed column units, and the beet sugar solution before boiling is demineralized under the following conditions: starting solution feed rate/eluent water feed rate volume ratio=1/2.5 to 1/3.5, strong-affinity component fraction withdrawal rate/weak-affinity component fraction withdrawal rate volume ratio=0.5/1 to 1.2/1, and circulating flow rate=25 to 80 vol. % /hr. based on chromatographic packing in a slowest flow velocity zone in the circulation system, whereby a sucrose fraction having a high sucrose concentration is obtained using a small amount of eluent water with a large throughput.
Patent AT-E314396-T1 (AT)
Inventor: NI BAOFU
IPC: G01N33/50
Filed: 1999-04-30
Granted: 2006-01-15
Abstract: The invention relates to agonist molecules which specifically bind to or interact with human G-CSF receptor and dimerize the receptor or activate phosphorylation of kinases associated with the receptor to stimulate cell proliferation and differentiation. Such agonist molecules include monoclonal antibodies, or fragments, homologues or analogues thereof, or peptides or organic compounds. Two examples of mouse monoclonal agonist antibodies are disclosed: mAb163-93 and mAb174-74-11.
Patent AT-E256767-T1 (AT)
Inventor: SHUBKIN RONALD L
IPC: C11D7/30
Filed: 1999-06-09
Granted: 2004-01-15
Abstract: Silver tarnishing is inhibited when using ether stabilized, n-propyl bromide based cleaning compositions by including a saturated aliphatic alcohol in the compositions.
Patent AT-E290910-T1 (AT)
Inventor: CIVAN MORTIMER M
IPC: A61K9/08
Filed: 1999-07-15
Granted: 2005-04-15
Abstract: A method for decreasing intraocular pressure by administering an A3 subtype adenosine receptor antagonist, a calmodulin antagonist or an antiestrogen such as tamoxifen. These agents, by inhibiting influx or promoting efflux of aqueous humor, can be used to treat glaucoma.
Patent AT-E331726-T1 (AT)
Inventor: MONAGHAN SANDRA MARINA
IPC: C07D473/34
Filed: 1999-10-05
Granted: 2006-07-15
Abstract: The present invention provides compounds of formula (I):and pharmaceutically acceptable salts and solvates thereof, together with processes for the preparation of, compositions containing, uses of and intermediates used in the preparation of such compounds that have A2a receptor agonist activity.
Patent AT-E311202-T1 (AT)
Inventor: FLORENCE ALEXANDER
IPC: C12N15/09
Filed: 1999-09-23
Granted: 2005-12-15
Abstract: Dendrimers comprising a dentritic polypeptide with one dendron having terminal cationic groups and a lipidic anchor, preferably comprising C<SUB>6-24</SUB>-alkyl group containing alpha-amino acyl groups, preferably joined to the focal group, are used to assist transfection of cells in vitro and in vivo by DNA. The complex of dendrimer and DNA may be used in gene therapy, for instance to delivery clotting factor genes to cells.
Patent AT-E395594-T1 (AT)
Inventor: LYNGBERG OLAV K
IPC: C12Q1/02
Filed: 1999-09-17
Granted: 2008-05-15
Abstract: The present invention provides composite biological devices that include biological material as an integral component thereof. The devices can be used for measuring metals, for example, particularly toxic metals such as mercury.
Patent AT-E269114-T1 (AT)
Inventor: MOUSSY FRANCIS
IPC: A61B5/00
Filed: 1999-11-19
Granted: 2004-07-15
Abstract: A generic implantable puck that can be used with a number of biosensor configurations. This generic implantable potentiostat telemetry unit (the puck) can also be part of a system to detect glucose concentrations. An electrochemical system partially implantable into a body for detecting glucose concentrations therein is presented. The system comprises an electrochemical sensor, a transmitting puck including an electric circuit connected to the electrochemical sensor for transmitting a signal indicative of the glucose concentrations in the body. There is at least one receiver for receiving the signal from the transmitting puck and a computer system coupled tlo the at least one receiver for processing the signal for patient diagnosis and treatment.
Patent AT-E420531-T1 (AT)
Inventor: FREIMANN FELIX
IPC: H04N7/08
Filed: 1999-11-22
Granted: 2009-01-15
Abstract: A method for acquiring and storing schedule event information in an interactive television system. The schedule event information includes events and a start time and date for each of the events. The method includes creating a window defined by a start time and date and an end time and date and receiving the schedule event information at a receiving system (24). The schedule event information is stored for events having a start time and date within the window. The method further includes automatically moving the window forward relative to the start time and date at a specified interval such that the end time and date of the window are always after a current time and date. A system for acquiring and storing schedule event information is also disclosed.
Patent AT-E278979-T1 (AT)
Inventor: HEIDEL ROLAND
IPC: G05B19/418
Filed: 1999-12-10
Granted: 2004-10-15
Abstract: A distributed control system having system components ( 1, 2, 3 ). The positions of the system components ( 1, 2, 3 ) are stored in respective memories ( 11, 12, 13 ) as component-specific data, which represent the spatial coordinates of the positions. The system components ( 1, 2, 3 ) transmit their respective positions to a configuration unit ( 4 ) via a communications channel ( 5 ). By means of a layout plan, e.g., in the form of a piping and installation diagram, the component-specific data of the individual system components ( 1, 2, 3 ) is assigned to the configured system components. In addition, a respective physical address is assigned to each of the system components ( 1, 2, 3 ). This achieves simple and reliable configuration of the system components ( 1, 2, 3 ). The distributed control system is used, in particular, in process apparatuses.
Patent DE-02763890-T1 (DE)
Title: Graphitartikel mit vorbestimmten anisotropen eigenschaften und verfahren dafür
Inventor: MERCURI ROBERT ANGELO
IPC: C04B35/536
Filed: 2002-04-01
Abstract: Verfahren
zum Herstellen eines Graphitfertigartikels mit einer vorbestimmten
anisotropen Charakteristik, wobei das Verfahren aufweist:  a.
Bestimmen der gewünschten
anisotropen Charakteristik für
einen flexiblen Graphitfertigartikel;  b. Einlagern und anschließend Abblättern von
Graphitflocken zum Bilden abgeblätterter
Graphitpartikeln;  c. Bilden eines Substratgraphitartikels durch
Zusammenpressen der abgeblätterten
Graphitpartikeln zu einem kohärenten
Artikel aus Grapheneschichten;  d. Erzeugen einer gesteuerten
Richtungsausrichtung der Grapheneschichten in dem Substratgraphitartikel,
um einen Graphitfertigartikel mit den gewünschten anisotropen Charakteristiken
zu schaffen.
Patent DE-30413-T1 (DE)
IPC: G07F7/02
Filed: 1980-10-28
Abstract: A system for handling valuable documents within a monetary institution includes a main data processor (HD) and a plurality of control units (SE) or branch data processors (FD). Arranged to co-operate with those control units or branch data processors is a document-handling intermediate means (IE, UE) said means having individually identifiable cassettes. Means are provided which when there is relative movement between a cassette (K1) and a document-handling intermediate means (IE) and when there is relative movement between a document and a document-handling intermediate means (IE), enable information concerning such relative movement to be sent to the main data processor (HD) so that said main data processor contains available information concerning the identity of the cassettes and their possible connection to the document-handling intermediate means (IE, UE), and the document content of the cassettes. The cassettes are provided with electronic locks activatable from the data processors (FD, HD). The data processors are provided with monitoring means, arranged to ensure that the cassettes are inserted and removed before the lapse of a given time limit.
Patent DE-262690-T1 (DE)
IPC: G11B5/596
Filed: 1983-05-06
Abstract: A method for use in a magnetic disk drive of the type in which a disk assembly has a dedicated servo surface containing circular tracks of dedicated servo signals (75) and data surfaces containing circular data tracks divided into sectors each of which includes a data field (256) and a servo field (254) containing embedded servo signals, a dedicated servo signal detector for detecting servo signals (75) on said dedicated surface, an embedded signal detector for detecting embedded servo signals (254) on a data surface and a head positioning system for positioning a read/write head over a selected data track. The entire output of the embedded signal detector is combined with the high-frequency components of the output of the dedicated signal detector to produce a composite track error signal and the head positioning system responds to the composite track error signal to maintain the read/write head over the selected data track.
Patent DE-490183-T1 (DE)
IPC: A61P9/08
Filed: 1991-11-29
Abstract: Benzoxazinone and benzothiazinone derivatives of formula <CHEM> wherein R represents hydrogen, (C2-6)alkyl, (C5-7)cycloalkyl, phenyl, substituted phenyl; R1 and R2 independently represent hydrogen, halogen, (C1-4)alkyl, (C1-4)alkoxy or trifluoromethyl; X is oxigen or sulfur; Y is (C2-6)alkylene or (C5-7)cycloalkylene; and salts therewith of pharmaceutically acceptable acids. The compounds possess cardiovascular activity with high specificity for the coronary district.
Patent ES-2041623-T1 (ES)
Title: Arrollador de cinturon de traccion compensada en sistemas de retencion de cinturon de seguridad en vehiculos.
IPC: B60R22/44
Filed: 1991-11-21
Abstract: UN ENROLLADOR DE CINTURON CON MEDIOS DE RETRACCION EN SISTEMAS DE RETENCION DE CINTURONES DE SEGURIDAD, CONTIENE UN RESORTE ENROLLADOR (6) Y UN RESORTE AUXILIAR (8) DIMENSIONADO MAS DEBIL QUE ESTE. EL RESORTE ENROLLADOR (6) ACTUA ENTRE UNA CARCASA (10) DEL PROPIO ENROLLADOR Y UNA RECEPCION DEL RESORTE (12). EL RESORTE AUXILIAR (8) ACTUA ENTRE LA RECEPCION DEL RESORTE (12) Y LA BOBINA DEL CINTURON (2). POR EL BLOQUEO DE UNA RUEDA DE TRINQUETE (48) GIRABLE DE FORMA LIMITADA RESPECTO A LA RECEPCION DEL RESORTE (12), PUEDE CAMBIARSE ENTRE UNA POSICION NORMAL, EN EL QUE TAN SOLO EL RESORTE ENROLLADOR (6) DETERMINA EL EFECTO DE LA FUERZA DE TRACCION AUTOMATICA DEL CINTURON, Y UNA POSICION DE CONFORT, EN EL QUE TAN SOLO ACTUA EL RESORTE AUXILIAR (8). ENTRE LA RECEPCION DEL RESORTE (12) Y LA BOBINA (2) ACTUA UN FRENO DE FRICCION (22, 24) PARA AMORTIGUAR UN PROCESO DE TENSION DEL RESORTE AUXILIAR (8) POR EL RESORTE ENROLLADOR (6) AL CAMBIAR DE LA POSICION DE CONFORT A LA POSICION NORMAL. EL DISPOSITIVO DE FRENADO (22,24) ES SELECTIVAMENTE AJUSTABLE MEDIANTE LA PERCEPCION DEL GIRO RELATIVO ENTRE LA RECEPCION DEL RESORTE (12) Y LA RUEDA DE TRINQUETE (48), DE TAL MODO QUE ES INACTIVO EN LA POSICION DE CONFORT DEL ENROLLADOR DEL CINTURON.
Patent ES-2029988-T1 (ES)
Title: Metodo de procesar llamadas telefonicas.
IPC: H04M3/523
Filed: 1991-05-14
Abstract: UN METODO PARA OPTIMIZAR EL AVANCE Y PROCESAMIENTO DE LLAMADAS DE LLEGADA Y DE LLAMADAS DE SALIDA. SE GENERAN ESTADISTICOS RELATIVOS A LLAMADAS DE ENTRADA Y LLAMADAS DE SALIDA, Y RELATIVOS A LA EJECUCION DE CADA AGENTE PARA LLAMADAS DE ENTRADA Y DE SALIDA. LOS ESTADISTICOS SEPARADOS RELATIVOS A LLAMADAS DE ENTRADA Y DE SALIDA PERMITEN UNA MAYOR EXACTITUD EN LA PREDICCION DE AVANCE DE LLAMADAS Y REQUERIMIENTOS DE SOPORTE Y DISPONIBILIDAD DE UN AGENTE O FACILIDAD, DE FORMA QUE SE MAXIMICE LA PRODUCTIVIDAD DE CADA FACILIDAD Y EL CONTROL DEL TIEMPO DE MANTENIMIENTO DE LAS LLAMADAS DE ENTRADA Y DE SALIDA. CADA LINEA DE UNION SE DESIGNA PARA LLAMADAS DE ENTRADA Y DE SALIDA Y SE MONITORIZA EL ESTADO DE CADA UNA DE ELLAS. SI TODOS LOS ENLACES EN SITUACION DE OFRECER SERVICIO DE LLAMADAS DE ENTRADA SE ENCUENTRAN OCUPADOS, OCURRE QUE SE REALIZA UNA REASIGNACION SOBRE LOS ENLACES QUE OFRECEN SERVICIO PARA LLAMADAS DE SALIDA, DE FORMA QUE PASAN A SER UTILIZADOS ALGUNOS DE ELLOS PARA REALIZAR SERVICIOSDE LLAMADAS DE ENTRADA. SI OCURRE QUE HAY ENLACES DESIGNADOS PARA OFRECER SERVICIO DE LLAMADAS DE ENTRADA QUE NO ESTAN SIENDO UTILIZADOS, SON REASIGNADOS PARA OFRECER SERVICIOS DE LLAMADAS DE SALIDA. EL RATIO DE PETICION DE LLAMADAS DE LLEGADA Y EL DE ESTABLECIMIENTO DE LLAMADAS DE SALIDA, Y LA COLOCACION DE ENLACES ENTRE LLAMADAS DE ENTRADA Y LLAMADAS DE SALIDA SON FUNCION DE LA FRECUENCIA, DURACION Y NUMERO DE LLAMADAS, Y OPCIONES SELECCIONABLES POR EL USUARIO.
Patent ES-2061419-T1 (ES)
Title: Derivados de benzofurano y su uso como estabilizadores contra las radiaciones uv.
Inventor: RASPANTI GIUSEPPE
IPC: A61K8/49
Filed: 1994-02-21
Abstract: COMPUESTOS DE LA FORMULA I EN LA QUE R-R4 SON COMO SE DEFINE EN LA DESCRIPCION, TIENEN UNA ACTIVIDAD ESTABILIZANTE CONTRA LA RADIACION UV Y SON UTILES EN COSMETICA Y DERMATOLOGIA.
Patent CY-1107367-T1 (CY)
Inventor: GARCIA ALPHONSE
IPC: C07K7/06
Filed: 2008-03-27
Abstract: The invention relates to methods for identifying novel PP1-interacting polypeptides and proteins, compounds which are able to inhibit the binding of PP1c to certain factors naturally interacting with it, especially proteins of the Bcl-2 family (such as Bcl-x L  and Bcl-w), and pharmaceutical compositions comprising the same. The invention is based on the identification of a new PP1- binding motif having the sequence FXX[RK]X[RK], wherein X is any amino acid.
Patent CY-1109739-T1 (CY)
Inventor: LAMBERTZ BODO W
IPC: A41B11/00
Filed: 2010-01-15
Abstract: A sock for use in athletic activities comprises at least one substantially rod-shaped pad ( 3 ) in the area of the ankle region of the sock. In preferred embodiments, the sock includes at least two such rod-shaped-pads, which are preferably of different lengths and arranged essentially parallel to one another. Preferably, air channels ( 25 ) are provided on at least one surface of the sock (e.g. made from a climate regulating knit mesh fabric). In other embodiments the sock includes at least one climate channel ( 26 ) is in the tread area ( 13 ) of the sock.
Patent CY-1110291-T1 (CY)
Inventor: BHATTI BALWINDER S
IPC: C07D487/10
Filed: 2010-02-25
Abstract: Compounds, pharmaceutical compositions including the compounds, and methods of preparation and use thereof are disclosed. The compounds are bridged analogues of N-heteroaryl diazaspirocyclic compounds, or prodrugs or metabolites of these compounds. The aryl group can be a five or six-membered heterocyclic ring (heteroaryl). The compounds and compositions can be used to treat and/or prevent a wide variety of conditions or disorders, particularly those disorders characterized by dysfunction of nicotinic cholinergic neurotransmission, including disorders involving neuromodulation of neurotransmitter release, such as dopamine release. CNS disorders, which are characterized by an alteration in normal neurotransmitter release, are another example of disorders that can be treated and/or prevented. The compounds and compositions can also be used to alleviate pain. The compounds can (i) alter the number of nicotinic cholinergic receptors in the brain of the patient, (ii) exhibit neuroprotective effects and (iii) when employed in effective amounts, not result in appreciable side effects (e.g. side effects such as significant increases in blood pressure and heart rate, significant negative effects upon the gastrointestinal tract, and significant effects upon skeletal muscle).
Patent CY-1110244-T1 (CY)
Title: Χαμηλης υγροσκοπικοτητας αριπιπραζολη ως φαρμακευτικη ουσια και μεθοδοι για την παρασκευη της
Inventor: BANDO TAKUJI
IPC: C07D215/22
Filed: 2010-07-05
Abstract: Η παρούσα εφεύρεση παρέχει χαμηλής-υγροσκοπικότητας μορφές της αριπιπραζόλης και μέθοδους για την παρασκευή αυτών των μορφών, οι οποίες δεν θα μετασχηματιστούν σε ενυδρίτες ή δε θα χάσουν την αρχική τους διαλυτότητα ακόμα και όταν ένα φάρμακευτικό παρασκεύασμα που περιέχει τους άνυδρους κρυστάλλους αριπιπραζόλης αποθηκεύεται για μία μακρά περίοδο.
Patent CY-1111257-T1 (CY)
Title: Χρηση της αγομελατινης για τη ληψη φαρμακων προοριζομενων για τη θεραπεια των διπολικων διαταραχων
Inventor: DE BODINAT CHRISTIAN
IPC: A61P25/24
Filed: 2011-02-23
Abstract: Η παρούσα εφεύρεση αναφέρεται στην χρήση της αγομελατίνης ή Ν-[2-(7-μεθοξυ-1-ναφθυλ) αιθυλ] ακεταμιδίου μόνης ή σε συνδυασμό με άλατα λιθίου ή βαλπροάτη για τη λήψη φαρμάκων προοριζόμενων για τη θεραπεία των διπολικών διαταραχών, ιδίως των διπολικών διαταραχών τύπων I και II, και πιο συγκεκριμένα των διπολικών διαταραχών τύπου I.
Patent CY-1112964-T1 (CY)
Inventor: CAWTHRAY RICHARD JAMES
IPC: A61J1/03
Filed: 2011-12-16
Abstract: A kit for promoting the proper sequential oral administration of a pharmaceutically active ingredient and accompanying nutrients, said kit comprising: (a) at least one unit dose of a pharmaceutical active to be given continuously on a frequency of once a week, twice a week, once every two weeks, twice a month, or once a month; (b) at least one unit dose of a nutrient to be given subsequent to the active dose administration; and (c) a blister card individually and releasably containing the unit doses; wherein said unit doses of pharmaceutical active and nutrient are arranged horizontally or vertically in order of their use across the blister card is useful for aiding in patient understanding and complying with dosage regimens wherein the active ingredient is administered on a continuous frequency other than daily and the nutrient is administered on the days in between the days the active ingredient is administered.
Patent CY-1113758-T1 (CY)
Title: Γονιδιακη μεταφορα με την μεσολαβηση φορεα λεντοϊων και χρησεις αυτης
Inventor: STOUT J TIMOTHY
IPC: A61K35/00
Filed: 2012-11-22
Abstract: Η παρούσα εφεύρεση παρέχει ένα μέσο γονιδιακής θεραπείας του ανθρώπου για κληρονομική ή επίκτητη παραγωγική οφθαλμική νόσο. Παρέχει μεθόδους εξέτασης της ικανότητας των φορέων λεντοϊών να μετάγουν μιτωτικά ενεργά και ανενεργά κύτταρα, ώστε να μπορούν να θεραπευθούν ασθένειες του ματιού.
Patent CY-1113841-T1 (CY)
Title: Μεθοδος και συνθεση για την θεραπεια ουλων
Inventor: STUDIN JOEL R
IPC: A61K45/00
Filed: 2013-03-20
Abstract: Μέθοδος και σύνθεση για θεραπεία υπερτροφικών ουλών, έτσι ώστε να μειώνεται το μέγεθος και να γίνεται αποδεκτή η εμφάνιση ουλών, περιλαμβάνουσα εφαρμογή στην ουλή μιας σύνθεσης που περιλαμβάνει φορέα σχηματισμού φιλμ, όπως κολλοδίου, η οποία περιέχει ένα ή περισσότερα δραστικά συστατικά, όπως τοπικό στεροειδές, πηκτή σιλικόνης και βιταμίνη Ε. Νέες συνθέσεις χρησιμοποιώντας τον φορέα σχηματισμού φιλμ κολλόδιο επίσης είναι χρήσιμες για να θεραπεύεται μια ποικιλία δυσμενών δερματικών διαταραχών.
Patent CY-1114154-T1 (CY)
Title: Βελτιωσεις σχετικες με διαδικασιες εκτυπωσης και εκτυπωμενα προϊοντα
Inventor: MOROSS RICHARD
IPC: G06F17/21
Filed: 2013-06-20
Abstract: Περιγράφεται ένα σύστημα για την δημιουργία ενός ηλεκτρονικού εγγράφου προς χρήση σε μία διαδικασία εκτύπωσης. Το ηλεκτρονικό έγγραφο περιλαμβάνει μία πολλαπλότητα εκτυπώσιμων φύλλων, και κάθε εκτυπώσιμο φύλλο περιλαμβάνει μία συστοιχία εκτυπώσιμων περιοχών. Το σύστημα περιλαμβάνει μέσα λήψης διευθετημένα έτσι ώστε να λαμβάνουν περιεχόμενο από μία πολλαπλότητα χρηστών και μέσα αντιστοίχισης διευθετημένα να αντιστοιχίζουν μία επιλογή εκτυπώσιμων περιοχών για κάθε χρήστη σε εξάρτηση με το λαμβανόμενο περιεχόμενο για κάθε χρήστη και να αντιστοιχίζουν το περιεχόμενο για κάθε χρήστη εντός της επιλογής των εκτυπώσιμων περιοχών που έχουν αντιστοιχιστεί σε αυτό τον χρήστη. Το σύστημα είναι διευθετημένο ώστε να λαμβάνει το περιεχόμενο και να αντιστοιχίζει μία επιλογή εκτυπώσιμων περιοχών έτσι ώστε το περιεχόμενο για κάθε χρήστη, να μεταβάλλεται εντός της επιλογής των εκτυπώσιμων περιοχών που έχουν αντιστοιχιστεί σε αυτό τον χρήστη.
Patent CY-1114260-T1 (CY)
Title: 17-υδροξυ-17-πενταφθοροαιθυλο-οιστρα-4,9(10)-διεν-11-αρυλο-παραγωγο, μεθοδοι για την παραγωγη αυτου και χρηση αυτου για την αγωγη παθησεων
Inventor: SCHWEDE WOLFGANG
IPC: C07J41/00
Filed: 2013-06-26
Abstract: Η εφεύρεση σχετίζεται με 17-υδροξυ-17-πενταφθοροαιθυλο-οιστρα-4,9(10)-διεν-11 -αρυλο παράγωγα του τύπου (Ι) που εμφανίζουν επιδράσεις ανταγωνιστικές της προγεστερόνης και με μεθόδους για την παραγωγή αυτών, με τη χρήση αυτών για την αγωγή και/ή προφύλαξη παθήσεων και με τη χρήση αυτών για την παραγωγή φαρμάκων προοριζόμενων για την αγωγή και/ή προφύλαξη παθήσεων, ιδίως ινομυωμάτων μήτρας (μυώματα, λειομυώματα μήτρας), ενδομητρίωσης, εμμηνορραγίας, μηνιγγιωμάτων, ορμονοεξαρτώμενων καρκινωμάτων μαστού και ενοχλήσεων σχετιζόμενων με την εμμηνόπαυση ή για τον έλεγχο γονιμότητας και αντισύλληψη μετά από συνουσία.
Patent CY-1118543-T1 (CY)
Title: Μεθοδοι αγωγης χρησιμοποιωντας φαρμακευτικες ουσιες συλληψης αμμωνιας
Inventor: SCHARSCHMIDT BRUCE
IPC: G01N33/68
Filed: 2016-09-28
Abstract: Η εφεύρεση παρέχει μέθοδο για προσδιορισμό δόσης και σχεδίου και για πραγματοποίηση ρυθμίσεων ως προς τη δόση ΡΒΑ προφαρμάκων χρησιμοποιούμενων για την αγωγή καταστάσεων κατακράτησης αζώτου, ή διαταραχών συσσώρευσης αμμωνίας, μέσω μέτρησης της ουρικής απέκκρισης φαινυλακετυλογλουταμίνης και/ή του ολικού αζώτου ούρων. Η εφεύρεση παρέχει μεθόδους για την επιλογή κατάλληλης δοσολογίας ΡΒΑ προφαρμάκου με βάση την πρόσληψη διαιτητικής πρωτεΐνης του ασθενούς, ή με βάση προηγούμενες αγωγές χορηγηθείσες στον ασθενή. Οι μέθοδοι έχουν εφαρμογή στην επιλογή ή τροποποίηση του σχεδίου δοσολόγησης για υποκείμενο που λαμβάνει από του στόματος χορηγούμενη φαρμακευτική ουσία σύλληψης αμμωνίας.
Patent GR-960300011-T1 (GR)
Title: Raw extracts of blue algae, method of preparation and applications in cosmetology and dermatology.
Inventor: PEPIN DENISE
IPC: A61K8/97
Filed: 1996-03-31
Abstract: Raw extracts of blue algae (cyanophyceae), methods of preparation and applications in cosmetology and dermatology are disclosed. Said raw extracts of blue algae contain at least one substance selected from the following porphin ring derivatives: chlorophylls, chlorophyllides, chlorophyllines, phaeophytines and phaeophorbides, and may be obtained from a blue algae of the genus (Plectonema) by decoction or maceration of said algae, lyophilised or fresh, at a temperature from 20  C to 60  C in a solvent selected from the group consisting of mineral oils, vegetable oils, synthetic substitutes of natural oils, slightly polar organic solvents, water and solvents miscible with water.